Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Adriablastin
2. Adriablastine
3. Adriamycin
4. Adriblastin
5. Adriblastina
6. Adriblastine
7. Adrimedac
8. Doxo Cell
9. Doxo-cell
10. Doxolem
11. Doxorubicin
12. Doxorubicin Hexal
13. Doxorubicin Nc
14. Doxorubicina Ferrer Farm
15. Doxorubicina Funk
16. Doxorubicina Tedec
17. Doxorubicine Baxter
18. Doxotec
19. Farmiblastina
20. Hydrochloride, Doxorubicin
21. Myocet
22. Onkodox
23. Ribodoxo
24. Rubex
25. Urokit Doxo Cell
26. Urokit Doxo-cell
1. 25316-40-9
2. Doxorubicin Hcl
3. Rubex
4. Adriacin
5. Adriblastina
6. Caelyx
7. Doxil
8. Adriamycin Hydrochloride
9. Doxorubicin (adriamycin) Hcl
10. Adriamycin, Hydrochloride
11. Doxorubicin (hydrochloride)
12. Hydroxydaunorubicin Hydrochloride
13. Adriablastina Cs
14. Adriblastin
15. Nsc 123127
16. Hydroxydaunomycin Hydrochloride
17. Mls001401460
18. 82f2g7bl4e
19. Adm Hydrochloride
20. Lipodox
21. Smr000058570
22. Adriamycin Pfs
23. Adriamycin Rdf
24. Dsstox_cid_10636
25. Dsstox_rid_78854
26. Dsstox_rid_80678
27. Dsstox_gsid_30636
28. Dsstox_gsid_45111
29. (8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
30. (8s,10s)-10-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione Hydrochloride
31. Adrosal
32. Duxocin
33. Doxorubicin Citric Acid Salt
34. Adriamycin Hydrochloride-dna Complex
35. Mls000028393
36. Mfcd00077757
37. Lipo-dox
38. Fi 6804
39. (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride
40. (8s-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione Hydrochloride
41. Nsc-123127
42. Sr-01000003049
43. Kw-125
44. Unii-82f2g7bl4e
45. Resmycin
46. Ccris 740
47. Doxorubicin.hcl
48. Doxorubicin Hydrochloride [jan]
49. Doxorubicin, Hcl
50. Adriamycin (tn)
51. Adriacin (tn)
52. (1s,3s)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranoside Hydrochloride
53. (8s,10s)-10-((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
54. (8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione Hydrochloride
55. Prestwick_188
56. Einecs 246-818-3
57. Doxorubicin Hydrochloride [usp:jan]
58. Doxil (tn)
59. Rubex (tn)
60. Cpd000058570
61. Adriblastina Hydrochloride
62. (8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen
63. Dox
64. Adriamycin [iarc]
65. Doxorubicini Hydrochloridum
66. Ncgc00163543-01
67. Schembl3242
68. Cas-25316-40-9
69. Mls000049969
70. Mls000049970
71. Mls000049971
72. Mls000070047
73. Mls000392861
74. Mls000392871
75. Mls000392881
76. Mls000392891
77. Mls000392901
78. Mls000759533
79. Mls001055359
80. Doxorubicin Hydrochloride,(s)
81. Chembl359744
82. Dtxsid3030636
83. Chebi:31522
84. Doxorubicin Hydrochloride- Bio-x
85. Doxorubicin Hydrochloride Solution
86. Liposomal Doxorubicin Hydrochloride
87. Bcpp000429
88. Hms1569g18
89. Kuc110341c
90. Ex-a1337
91. Tox21_110050
92. Tox21_112061
93. Tox21_202483
94. Adriamycin (doxorubicin Hydrochloride
95. S1208
96. Akos007930231
97. Akos015920241
98. Doxorubicin Hydrochloride (jp17/usp)
99. Tox21_110050_1
100. Bcp9000237
101. Ccg-100975
102. Cs-1239
103. Nc00225
104. 2-chloro-4-fluorobenzenesulphonylchloride
105. Doxorubicin Hydrochloride [mart.]
106. Doxorubicin Hydrochloride [vandf]
107. Doxorubicin Hydrochloride Liposome
108. Ncgc00014486-01
109. Ncgc00024415-33
110. Ncgc00024415-36
111. Ncgc00260032-01
112. Ncgc00263918-03
113. (8s,10s)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride
114. As-31687
115. Bd164391
116. Doxorubicin Hydrochloride [usp-rs]
117. Doxorubicin Hydrochloride [who-dd]
118. Doxorubicin Hydrochloride [who-ip]
119. Hy-15142
120. Ksc-230-184-1
121. Doxorubicin Hydrochloride [ema Epar]
122. D01275
123. Doxorubicin Hydrochloride [ep Monograph]
124. Doxorubicin Hydrochloride [orange Book]
125. Doxorubicin Hydrochloride [usp Monograph]
126. 316d409
127. A817779
128. Doxorubicin Hydrochloride Liposome [vandf]
129. Doxorubicin Liposomal Complex Of The Hydrochloride
130. Doxorubicini Hydrochloridum [who-ip Latin]
131. Doxorubicin Hydrochloride, 98.0-102.0% (hplc)
132. Imx-110 Component Doxorubicin Hydrochloride
133. Liposomal Doxorubicin Hydrochloride [who-dd]
134. Sr-01000003049-5
135. Q27032359
136. Sr-01000003049-10
137. Z1557399790
138. Doxorubicin Liposomal Complex Of The Hydrochloride [mi]
139. Doxorubicin Hydrochloride, European Pharmacopoeia (ep) Reference Standard
140. Doxorubicin Hydrochloride, Suitable For Fluorescence, 98.0-102.0% (hplc)
141. Doxorubicin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
142. Doxorubicin Hydrochloride, United States Pharmacopeia (usp) Reference Standard
143. (8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
144. (8s,10s)-10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride
145. 10-[(3-amino-2,3,6-trideoxy-?-l-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione Hydrochloride
146. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, Hydrochloride (8s-cis)-
147. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, Hydrochloride, (8s,10s)-
148. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, Hydrochloride, (8s-cis)-
149. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, Hydrochloride (8s-cis)-
Molecular Weight | 580.0 g/mol |
---|---|
Molecular Formula | C27H30ClNO11 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 5 |
Exact Mass | 579.1507385 g/mol |
Monoisotopic Mass | 579.1507385 g/mol |
Topological Polar Surface Area | 206 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 977 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Doxorubicin hydrochloride |
PubMed Health | Doxorubicin Hydrochloride Liposome (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius. Doxorubicin consists of a naphthacenequinone nucleus linked through a glycosidic bond at ring atom 7 to an amino sugar, daunosamine. Ch... |
Active Ingredient | Doxorubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 2mg/ml; 10mg/vial; 200mg/100ml; 50mg/vial; 20mg/vial |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Pharmachemie Bv; Onco Therapies; Sun Pharm Inds; Teva Pharms Usa; Sagent Pharms; Eurohlth Intl; Alvogen; Sandoz; Actavis |
2 of 2 | |
---|---|
Drug Name | Doxorubicin hydrochloride |
PubMed Health | Doxorubicin Hydrochloride Liposome (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius. Doxorubicin consists of a naphthacenequinone nucleus linked through a glycosidic bond at ring atom 7 to an amino sugar, daunosamine. Ch... |
Active Ingredient | Doxorubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 2mg/ml; 10mg/vial; 200mg/100ml; 50mg/vial; 20mg/vial |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Pharmachemie Bv; Onco Therapies; Sun Pharm Inds; Teva Pharms Usa; Sagent Pharms; Eurohlth Intl; Alvogen; Sandoz; Actavis |
Myocet liposomal, in combination with cyclophosphamide, is indicated for the first-line treatment of metastatic breast cancer in adult women.
Caelyx pegylated liposomal is indicated:
- as monotherapy for patients with metastatic breast cancer , where there is an increased cardiac risk;
- for treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen;
- in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant;
- for treatment of AIDS-related Kaposis sarcoma (KS) in patients with low CD4 counts (< 200 CD4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease.
Caelyx pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in AIDS-KS patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standarddoxorubicin (or other anthracycline).
Treatment of breast and ovarian cancer .
Treatment of hepatocellular carcinoma
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
L01DB01
L01DB
L01DB01
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Certificate Number : R1-CEP 2004-059 - Rev 03
Issue Date : 2023-03-06
Type : Chemical
Substance Number : 714
Status : Valid
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-29
Pay. Date : 2012-11-08
DMF Number : 13726
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : CEP 2003-111 - Rev 06
Issue Date : 2024-05-29
Type : Chemical
Substance Number : 714
Status : Valid
Available Reg Filing : CA, ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24858
Submission : 2011-04-05
Status : Active
Type : II
Certificate Number : R1-CEP 2012-039 - Rev 01
Issue Date : 2020-01-02
Type : Chemical
Substance Number : 714
Status : Valid
Date of Issue : 2020-12-18
Valid Till : 2023-12-17
Written Confirmation Number : WC-0292
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-08-27
Pay. Date : 2024-07-18
DMF Number : 31153
Submission : 2016-11-11
Status : Active
Type : II
Certificate Number : R1-CEP 2016-254 - Rev 00
Issue Date : 2022-11-22
Type : Chemical
Substance Number : 714
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-10-18
Pay. Date : 2015-12-28
DMF Number : 13209
Submission : 1998-04-30
Status : Active
Type : II
Certificate Number : R1-CEP 2003-151 - Rev 03
Issue Date : 2020-04-02
Type : Chemical
Substance Number : 714
Status : Valid
Registration Number : 302MF10073
Registrant's Address : 2-4-16 Kyobashi, Chuo-ku, Tokyo
Initial Date of Registration : 2020-07-01
Latest Date of Registration :
NDC Package Code : 12543-3209
Start Marketing Date : 2010-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10g/10g)
Marketing Category : BULK INGREDIENT
Registrant Name : Boxter Co., Ltd.
Registration Date : 2021-02-17
Registration Number : 20210217-210-J-674
Manufacturer Name : Meiji Seika Pharma Co., Ltd. Kitakami Plant
Manufacturer Address : 3-3, Kitakogyodanchi Kitakami-shi, Iwate-ken 024-0193, Japan
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24128
Submission : 2010-08-31
Status : Inactive
Type : II
Date of Issue : 2016-02-23
Valid Till : 2019-02-23
Written Confirmation Number : WC-0357
Address of the Firm :
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Norway
Brand Name : Doxorubicin Accord
Dosage Form : Concentrate to the infusion fluid
Dosage Strength : 2 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Doxorubicin hydrochloride; PEG liposomal
Brand Name : Caelyx
Dosage Form : Inf Conc
Dosage Strength : 20mg/10ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Adriblastin Sol
Dosage Form : Inj L?s
Dosage Strength : 10mg/5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Generic
Registration Country : United Kingdom
Brand Name :
Dosage Form : SOLUTION
Dosage Strength : 10MG/5ML
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : United Kingdom
Regulatory Info :
Registration Country : Sweden
Brand Name : Myocet
Dosage Form : PULVER, DISPERSION OCH VÄTSKA TILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Myocet
Dosage Form : Doxorubicin 50Mg 2 Units Parenteral Use
Dosage Strength : 2 sets chk groun 50 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Brand Name : Doxorubicin-Teva
Dosage Form : Inj Solution
Dosage Strength : 10mg/5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Brand Name : Doxorubicin Ebewe
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 2 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : 1 Farmiblastina 10Mg Vial 1 Blister Powder And Solvent For Solution For Injection
Dosage Form : Powder For Oral Solution
Dosage Strength : 10 Mg/Powder for Oral Solution
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Doxorubicin Ebewe
Dosage Form : Injection fluid, resolution
Dosage Strength : 2 mg/ml
Packaging : Hood glass of dark glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DOXORUBICIN INJECTION, BP
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging : 5/25/100ML
Approval Date :
Application Number : 2381982
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CAELYX
Dosage Form : SUSPENSION
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number : 2238389
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 50MG/VIAL
Packaging : 25ML
Approval Date :
Application Number : 2194465
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 150MG/VIAL
Packaging : 75ML
Approval Date :
Application Number : 2194473
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DOXORUBICIN
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging : 5/25/100ML
Approval Date :
Application Number : 2410397
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : TARO-DOXORUBICIN LIPOSOMAL
Dosage Form : SUSPENSION
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number : 2493020
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DOXORUBICIN HYDROCHLORIDE INJECTION
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging : 5/25/100ML
Approval Date :
Application Number : 2409275
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rubexet 10mg/5ml
Dosage Form : INJ
Dosage Strength : 10mg/5ml
Packaging : 5X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : DOXORUBICIN 10mg/5ml FRESENIUS
Dosage Form : INJ
Dosage Strength : 10mg/5ml
Packaging : 5X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Doxred 50mg/25ml
Dosage Form : INF
Dosage Strength : 50mg/25ml
Packaging : 25X1mg/25ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : DOXORUBICIN-SOL PCH 50MG
Dosage Form : INJ
Dosage Strength : 50mg
Packaging : 25X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Caelyx
Dosage Form : INF
Dosage Strength : 2mg/ml
Packaging : 10X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Caelyx
Dosage Form : INF
Dosage Strength : 2mg/ml
Packaging : 25X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Sopilcin 20 mg/10 ml
Dosage Form : INF
Dosage Strength : 2mg/ml
Packaging : 10X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Doxorubicin - Pch 10
Dosage Form : INJ
Dosage Strength : 10mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Doxorubicin Pch 50
Dosage Form : INJ
Dosage Strength : 50mg
Packaging : 1X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Doxorubicin Rtu 200-100 100Ml
Dosage Form : INJ
Dosage Strength : 200mg/100ml
Packaging : 100X1mg/100ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Packaging :
Regulatory Info : Lead Market Dossiers- Filed
Dosage : Injection
Dosage Strength : 2MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved...
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved...
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Packaging :
Regulatory Info : Lead Market Dossiers- Approved...
Dosage : Injection
Dosage Strength : 20MG/10ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved...
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved...
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Packaging :
Regulatory Info : Lead Market Dossiers- Approved...
Dosage : Injection
Dosage Strength : 50MG/25ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 10MG/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Liquid Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Packaging :
Regulatory Info :
Dosage : Liquid Injection
Dosage Strength : 2MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 10MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Packaging :
Regulatory Info :
Dosage : Lyophilised Injection
Dosage Strength : 10MG/Vial
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 50MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Packaging :
Regulatory Info :
Dosage : Lyophilised Injection
Dosage Strength : 50MG/Vial
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : I-DOX
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging : 1 Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 1 Vial
Regulatory Info :
Dosage : Injection
Dosage Strength : 50MG/25ML
Brand Name : I-DOX
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : Doxonish 10
Dosage Form : INJECTION
Dosage Strength : 10MG
Packaging : 1 Vial
Approval Date :
Application Number : 50467
Regulatory Info : Generic
Registration Country : India
Packaging : 1 Vial
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 10MG
Brand Name : Doxonish 10
Approval Date :
Application Number : 50467
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging : 10 ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 10 ml
Regulatory Info :
Dosage : Injection
Dosage Strength : 2MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.
Pharmacopoeia Ref : DMF, EXCiPAT, KOSHER, HALAL, W...
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Starlose P40 (Starch & Lactose Monohydrate) is used as a diluent in oral dosage forms such as tablets.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Lactose Monohydrate
Application : Parenteral
Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
63
PharmaCompass offers a list of Doxorubicin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Doxorubicin Hydrochloride manufacturer or Doxorubicin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxorubicin Hydrochloride manufacturer or Doxorubicin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Doxorubicin Hydrochloride API Price utilized in the formulation of products. Doxorubicin Hydrochloride API Price is not always fixed or binding as the Doxorubicin Hydrochloride Price is obtained through a variety of data sources. The Doxorubicin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Doxorubicin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxorubicin HCl, including repackagers and relabelers. The FDA regulates Doxorubicin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxorubicin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxorubicin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxorubicin HCl supplier is an individual or a company that provides Doxorubicin HCl active pharmaceutical ingredient (API) or Doxorubicin HCl finished formulations upon request. The Doxorubicin HCl suppliers may include Doxorubicin HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Doxorubicin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Doxorubicin HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Doxorubicin HCl active pharmaceutical ingredient (API) in detail. Different forms of Doxorubicin HCl DMFs exist exist since differing nations have different regulations, such as Doxorubicin HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Doxorubicin HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Doxorubicin HCl USDMF includes data on Doxorubicin HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Doxorubicin HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Doxorubicin HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Doxorubicin HCl Drug Master File in Japan (Doxorubicin HCl JDMF) empowers Doxorubicin HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Doxorubicin HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Doxorubicin HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Doxorubicin HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Doxorubicin HCl Drug Master File in Korea (Doxorubicin HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxorubicin HCl. The MFDS reviews the Doxorubicin HCl KDMF as part of the drug registration process and uses the information provided in the Doxorubicin HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Doxorubicin HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxorubicin HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Doxorubicin HCl suppliers with KDMF on PharmaCompass.
A Doxorubicin HCl CEP of the European Pharmacopoeia monograph is often referred to as a Doxorubicin HCl Certificate of Suitability (COS). The purpose of a Doxorubicin HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Doxorubicin HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Doxorubicin HCl to their clients by showing that a Doxorubicin HCl CEP has been issued for it. The manufacturer submits a Doxorubicin HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Doxorubicin HCl CEP holder for the record. Additionally, the data presented in the Doxorubicin HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Doxorubicin HCl DMF.
A Doxorubicin HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Doxorubicin HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Doxorubicin HCl suppliers with CEP (COS) on PharmaCompass.
A Doxorubicin HCl written confirmation (Doxorubicin HCl WC) is an official document issued by a regulatory agency to a Doxorubicin HCl manufacturer, verifying that the manufacturing facility of a Doxorubicin HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Doxorubicin HCl APIs or Doxorubicin HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Doxorubicin HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Doxorubicin HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Doxorubicin HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Doxorubicin HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Doxorubicin HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Doxorubicin HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Doxorubicin HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Doxorubicin HCl suppliers with NDC on PharmaCompass.
Doxorubicin HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Doxorubicin HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Doxorubicin HCl GMP manufacturer or Doxorubicin HCl GMP API supplier for your needs.
A Doxorubicin HCl CoA (Certificate of Analysis) is a formal document that attests to Doxorubicin HCl's compliance with Doxorubicin HCl specifications and serves as a tool for batch-level quality control.
Doxorubicin HCl CoA mostly includes findings from lab analyses of a specific batch. For each Doxorubicin HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Doxorubicin HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxorubicin HCl EP), Doxorubicin HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxorubicin HCl USP).